Sign in

NCT06442163Completed

Average Volume-assured Pressure Support as Rescue Therapy in Obesity Hypoventilation Syndrome

Outcome Measures of Auto-titrating Average Volume-assured Pressure Support (AVAPS) as Rescue Therapy After CPAP Titration Failure in Patients With Obesity Hypoventilation Syndrome: Adherence and Sleep Quality

Source: ClinicalTrials.gov · Last updated 4 Jun 2024

Brief summary (registry, in English)

It remains unclear whether CPAP therapy should be prescribed if significant hypoxemia persists during CPAP titration, despite optimization of upper airway obstructive events, if maximum CPAP pressure is reached. The goal was to examine the effects of 6 months of home AVAPS therapy in patients with obesity hypoventilation syndrome as a potential option for patients who failed CPAP titration due to persistent hypoxemia.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
18 May 2024
Start date
12 May 2020
Primary completion date
30 Apr 2024
Lead sponsor
Assiut University
Diseases
Obesity
NCT number
NCT06442163

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 12 May 2020 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with evidence of acute respiratory failure (patients with worsening symptoms during the last 2 weeks before the screening visit, a breathing frequency of 30 breaths/ minute, or signs of respiratory infections)
  • Patients who had received any other form of ventilatory support before hospital admission were also excluded from the study

Other

  • Patients who had been intubated during the last 3 months

Who the study is looking for

  • All Clinically stable OHS patients with
    • Body mass index of 30 kg/m2 ,
    • Daytime hypercapnia (PaCO2 \>45 mm Hg) who had failed to respond to CPAP therapy
    • had no other cause for their chronic respiratory failure and were naive to any PAP therapy.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Assuit University Hospital
Coordinator of this site? Confirm its status
AsyutEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.